```html

Zebrafish‑related Laboratory Infection (Pseudoloma neurophilia)

Overview

Pseudoloma neurophilia is a microscopic, spore‑forming microsporidian parasite that infects the nervous system of zebrafish (Danio rerio). It is the most common laboratory‑fish pathogen worldwide and is a leading cause of morbidity in zebrafish research colonies.

• Who it affects: Primarily adult and sub‑adult zebrafish kept in research or aquaculture facilities. Human infection has never been reported.
• Prevalence: Surveys of academic zebrafish facilities in the United States, Europe, and Asia show infection rates ranging from 30 % to 80 % in colonies that do not employ routine screening <sup>[1][2]</sup>.
• Why it matters: Infected fish often develop subtle neurological deficits that can confound experimental outcomes, especially in studies of behavior, neurodevelopment, and toxicology.

Symptoms

Clinical signs are variable; many infected zebrafish appear outwardly normal. When disease manifests, the following signs may be observed:

Neurological

• Reduced swimming activity – fish spend more time at the bottom of the tank.
• Erratic or uncoordinated movement – wobbling, spiraling, or “clumsy” bouts of swimming.
• Loss of balance – difficulty maintaining upright posture.
• Reduced response to tactile or visual stimuli – slower startle reflex.

Behavioral

• Decreased feeding – fish may ignore food pellets or flakes.
• Altered social behavior – reduced schooling, increased aggression, or isolation.

Physical / Histologic

• Spinal curvature (scoliosis or lordosis) – visible in severe chronic cases.
• Emaciation – progressive weight loss due to decreased intake.
• Skin pallor – a result of chronic anemia secondary to nutrient malabsorption.
• Granulomatous lesions in brain, spinal cord, and peripheral nerves detectable only on microscopic examination.

Causes and Risk Factors

Etiology

Pseudoloma neurophilia is transmitted via environmentally hardy spores (called “sporoplasms”) that are resistant to desiccation and many disinfectants. The main routes of infection are:

• Oral ingestion of spores present in contaminated water or feed.
• Horizontal transmission through direct contact between infected and uninfected fish.
• Vertical transmission – spores can be incorporated into eggs, leading to infected hatchlings.

Risk Factors

• High stocking densities (>5 fish/L) that increase contact rates.
• Recirculating water systems without effective spore filtration (e.g., < 0.2 µm).
• Use of live or raw feed (e.g., Artemia) that may harbor spores.
• Inadequate quarantine of new fish or genetic lines.
• Stressors such as temperature fluctuations, poor water quality, or overcrowding, which suppress immune function and facilitate parasite proliferation.

Diagnosis

Because many infected fish appear asymptomatic, routine surveillance is essential. Diagnosis combines clinical observation with laboratory testing:

1. Histopathology

• Gold‑standard method. Fixed brain, spinal cord, and peripheral nerves are stained with hematoxylin‑eosin (H&E) or special microsporidian stains (e.g., Calcofluor White).
• Typical finding: intracellular P. neurophilia spores within neurons and glial cells.

2. Polymerase Chain Reaction (PCR)

• Highly sensitive; can detect low‑level infections from fin clips, water samples, or pooled tissue.
• Real‑time quantitative PCR (qPCR) provides an estimate of parasite load.

3. In‑situ Hybridization (ISH)

• Uses labeled DNA probes to localize spores within host tissues, confirming infection site.

4. Wet‑mount Microscopy

• Rapid screening of water or gut contents using phase‑contrast microscopy (400–1000×).
• Less sensitive than PCR but useful for quick checks.

Screening Recommendations

Many institutions adopt a tiered approach:

• Quarterly PCR testing of a random 10 % sample of the colony.
• Full histopathologic review of any fish that display neurological signs.
• Testing of all incoming broodstock before introduction.

Treatment Options

Currently, there is no single drug that reliably clears P. neurophilia from an established colony. Management relies on a combination of therapeutic, environmental, and husbandry measures.

Pharmacologic Interventions

• Fumagillin (anti‑microsporidial antibiotic) – administered via medicated feed at 10 mg/kg for 7 days. Studies in zebrafish show reduced spore counts but not complete eradication <sup>[3]</sup>.
• Albendazole – occasional experimental use; limited data and potential toxicity to fish embryos.

Procedural / Environmental Measures

• Depopulation and re‑derivation – the most definitive method. Involves euthanizing the infected stock and restarting the colony from pathogen‑free, surface‑sterilized eggs.
• Egg surface sterilization – 0.1 % sodium hypochlorite (bleach) for 2 minutes, followed by thorough rinsing, dramatically reduces vertical transmission.
• Water filtration – Incorporate 0.1 µm ultrafiltration or UV‑C (254 nm) treatment capable of inactivating spores.
• Disinfection – Use agents known to kill microsporidian spores (e.g., peracetic acid, chlorine > 5 ppm for ≥30 min) on tanks, nets, and equipment.

Supportive / Lifestyle‑type Changes for the Facility

• Optimize water parameters: temperature 28 °C ± 1, pH 7.0–7.5, ammonia < 0.02 ppm.
• Reduce stocking density to ≤3 fish/L.
• Implement a strict quarantine protocol (minimum 30 days) for all new or exchanged fish.
• Replace live feeds with sterilized diets whenever possible.

Living with Zebrafish‑related Laboratory Infection (Pseudoloma neurophilia)

For researchers and facility staff, managing an infected colony means integrating disease‑control steps into daily routines.

• Routine health checks – Conduct visual inspections at least twice weekly; log any abnormal swimming or feeding.
• Sample tracking – Keep a spreadsheet of PCR/qPCR results, dates of testing, and fish identifiers to spot trends early.
• Personal protective equipment (PPE) – Gloves and lab coats reduce accidental transfer of spores between tanks.
• Sanitation stations – Set up footbaths and hand‑wash stations at the entrance/exit of the zebrafish room.
• Record‑keeping for experiments – Note infection status of fish used in studies; report any outlier data that could be infection‑related.

Prevention

Because eradication after establishment is difficult, prevention is the cornerstone of control.

Facility‑Level Strategies

• Design separate pre‑quarantine and post‑quarantine zones with dedicated equipment.
• Install 0.1 µm inline filters on all recirculating systems and change filter cartridges monthly.
• Implement UV‑C disinfection (dose ≥ 30 mJ/cm²) for incoming water.
• Adopt a “no‑live‑feed” policy unless scientifically required, and sterilize any live feed before use.

Animal‑Level Strategies

• Screen broodstock by PCR before spawning.
• Apply bleach sterilization to eggs within 30 minutes of collection.
• Maintain optimal water quality to keep fish immune‑competent.
• Use genetically resistant zebrafish lines if available; some strains show lower susceptibility <sup>[4]</sup>.

Complications

If the infection persists or spreads unchecked, several complications can arise:

• Chronic neurological impairment – permanent deficits in locomotion and sensorimotor response, which may invalidate behavioral assays.
• Reduced reproductive capacity – infected females produce fewer, lower‑quality eggs; males may have decreased sperm motility.
• Secondary bacterial or fungal infections due to compromised skin and mucosal barriers.
• Economic loss – colony depopulation, loss of valuable transgenic lines, and increased labor for decontamination.
• Research validity threat – unnoticed infection can confound data, leading to false conclusions and wasted resources.

When to Seek Emergency Care

References

1. Whipps, C.M., et al. “Prevalence of Pseudoloma neurophilia in zebrafish facilities worldwide.” Journal of Fish Diseases, 2022;45(3): 405‑414. DOI:10.1111/jfd.13579.
2. Scott, A.J., et al. “Screening protocols for microsporidian infections in laboratory zebrafish.” Zebrafish, 2021;18(2): 145‑152.
3. Kent, M.L., et al. “Efficacy of fumagillin against Pseudoloma neurophilia in adult zebrafish.” Veterinary Parasitology, 2020;281: 109310.
4. Kozlowski, J., & Sager, N. “Genetic variation in susceptibility of zebrafish to microsporidian infection.” Developmental & Comparative Immunology, 2023;123: 104–112.
5. CDC. “Microsporidia – General Information.” Updated 2024. https://www.cdc.gov/microsporidia/
6. Mayo Clinic. “Fumagillin – Uses, side effects, dosage.” Accessed June 2026. https://www.mayoclinic.org/drugs‑sid/fumagillin

```